FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

685511000001105: Zanaflex 2mg tablets (Medeus Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16731301000001116 Zanaflex 2mg tablets (Medeus Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
67047001000001115 Zanaflex 2mg tablets (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zanaflex 2mg tablets (Medeus Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Is a Product containing precisely tizanidine (as tizanidine hydrochloride) 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has excipient Lactose false Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has active ingredient Tizanidine hydrochloride false Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Is a Zanaflex true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tizanidine true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has specific active ingredient Tizanidine hydrochloride true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) Has basis of strength substance Tizanidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zanaflex 2mg tablets (Medeus Pharma) 120 tablet 4 x 30 tablets Is pack of False Zanaflex 2mg tablets (Medeus Pharma) Inferred relationship Existential restriction modifier
Zanaflex 2mg tablets (Medeus Pharma) 120 tablet 4 x 30 tablets Has AMP True Zanaflex 2mg tablets (Medeus Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start